Developing a consumer reporting program in Malaysia: a novel initiative to improve pharmacovigilance
- 123 Downloads
The national pharmacovigilance program in Malaysia is limited to very few centers and under-reporting of adverse drug reactions (ADRs) is a major limitation. Studies from developed countries have documented the importance and usefulness of consumer reporting of ADRs. Involving consumers in ADR reporting can be very useful in improving the reporting rates in Malaysia. The present article highlights the proposed plan of initiating a consumer based pharmacovigilance program in University Wellness Center located inside the campus of the Universiti Sains Malaysia, Penang, Malaysia.
KeywordsAdverse drug reactions Consumer reporting Malaysia Pharmacovigilance
Conflict of interests
There was no conflict of interest influencing the publication of this article.
- 3.World Health Organization. Requirements for adverse reaction reporting. Geneva, Switzerland: World Health Organization; 1975.Google Scholar
- 4.World Health Organization. The importance of pharmacovigilance. Geneva, Switzerland: World Health Organization; 2002.Google Scholar
- 5.Haq ASM. Pharmacovigilance initiatives in Malaysia. Drug Info J. 2008;37:143 (S)–148 (S).Google Scholar
- 10.Medawar C, Herxheimer A. A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med. 2003;16:5–19.Google Scholar
- 11.Al-Haddad M, Izham MIM. The development of the discipline of social and administrative pharmacy at Universiti Sains Malaysia. South Med Rev. 2008;1:3–5.Google Scholar
- 12.Palaian S, Izham M, Mishra P. Monitoring adverse drug reactions using the community pharmacists: a preliminary study from Nepal. Drug Saf. 2008;31(10):885–960.Google Scholar